Nurix Therapeutics (NRIX) Selling, General & Administrative (2019 - 2026)
Nurix Therapeutics' Selling, General & Administrative came in at $15.59 million for fiscal Q2 2026 (quarter ended May 31, 2026), up 9.2% from $14.28 million a year earlier and up 6.7% from the prior quarter.
Nurix Therapeutics (NRIX) Selling, General & Administrative (2019 - 2026) Analysis & Trends
Over the trailing twelve months to May 31, 2026, Nurix Therapeutics reported Selling, General & Administrative of $57.01 million, up 17.9% year-over-year; for FY2025 (ended Nov 30, 2025), it was $52.74 million, up 14.8% from FY2024.
- Selling, General & Administrative has increased in each of the last six fiscal years, with a five-year compound annual growth rate of 26.5% (FY2020 to FY2025).
- Going back by fiscal year, Selling, General & Administrative was $45.94 million in FY2024 (+7.1%), $42.9 million in FY2023 (+12.9%), $38 million in FY2022 (+21.8%) and $31.2 million in FY2021 (+91.3%).
- The fiscal Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to fiscal Q3 2019.
- Year-over-year, Selling, General & Administrative has increased for five consecutive quarters, with growth averaging 13.1% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in fiscal Q3 2021 (growth of 92.3%), and the weakest in fiscal Q1 2025 (a decline of 1.2%).
- Business Quant data shows NRIX's Selling, General & Administrative at $14.61 million (Q1 2026), $13.65 million (Q4 2025) and $13.16 million (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Nurix Therapeutics | 2.46 Bn | 452.73 Mn | - | 15.59 Mn |
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 15.59 Mn |
| Feb 28, 2026 | 14.61 Mn |
| Nov 30, 2025 | 13.65 Mn |
| Aug 31, 2025 | 13.16 Mn |
| May 31, 2025 | 14.28 Mn |
| Feb 28, 2025 | 11.65 Mn |
| Nov 30, 2024 | 10.72 Mn |
| Aug 31, 2024 | 11.72 Mn |
| May 31, 2024 | 11.71 Mn |
| Feb 29, 2024 | 11.80 Mn |
| Nov 30, 2023 | 10.78 Mn |
| Aug 31, 2023 | 10.62 Mn |
| May 31, 2023 | 11.68 Mn |
| Feb 28, 2023 | 9.82 Mn |
| Nov 30, 2022 | 9.37 Mn |
| Aug 31, 2022 | 9.75 Mn |
| May 31, 2022 | 9.65 Mn |
| Feb 28, 2022 | 9.23 Mn |
| Nov 30, 2021 | 8.82 Mn |
| Aug 31, 2021 | 8.34 Mn |
Nurix Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();